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ABSTRACT Evidence that class I nuijor histocompatibility
complex-restricted cytotoxic T lymphocytes (CTL) are involved
in immunity to malaria has highlighted the potential importance
of these cells in protection against intracellular parasites. Par-
asite-specific CTL are a prominent feature of the immune
response of cattle to Theileria parva, a related apicomplexan
parasite. The relationship between the appearance of these cells
in the blood ofimmune cattle under challenge and the clearance
of infection suggests that they are involved in the control of
infection, but direct evidence is lacking that CTL can mediate
protection. We have made a quantitative kinetic study of CTL
responses in lymph originating from infected lymph nodes in a
number of immune cattle under challenge with T. parva. Direct
killing activity and the frequency of CTL precursors (CTLp)
within responding cell populations were evaluated. A substantial
increase in the proportion of CD8+ CTL was observed between
days 8 and 11 after challenge. Frequencies of CTLp as high as
1:32 were observed and activity was essentially confined to the
large blasting cell fraction. The analogous response in peripheral
blood was oflower magnitude and delayed by 1-2 days. The high
frequency of CTLp in efferent lymph permitted the adoptive
transfer of this activity between immune and naive monozygotic
twin calves. In separate experiments, naive calves lethally in-
fected with T. parya were protected by inoculation of up to 1010
responding CD8+ T cells derived from their immune twins.
Elimination of CD8+ T cells within the inoculum abrogated this
effect. These rmnding provide direct evidence that CD8+ T cells
can control T. parva infections in immune cattle.
Apicomplexan blood parasites constitute a serious threat to
large sections ofhuman and animal populations throughout the
world. Probably ofgreatest significance in the context ofThird
World development are the malaria infections of man and the
theilerioses of cattle. The life cycles of Plasmodium and
Theileria parasites are similar in that infection occurs through
inoculation ofthe sporozoite stage into the mammalian host by
an arthropod vector, and both parasites undergo asexual
schizogenous replication in nucleated cells prior to invasion of
erythrocytes. However, unlike Plasmodium, Theileria para-
sites invade leukocytes and it is their schizogenous rather than
intra-erythrocytic stage that is generally responsible for caus-
ing disease. There are also striking similarities in the immune
responses elicited by the early developmental stages of these
parasites. In both infections antibodies specific for sporozoite
surface antigens can be generated but, although they have
been shown to be protective under experimental conditions (1,
2), their presence does not correlate with protection in recov-
ered individuals (3-5). Cytotoxic CD8+ T-cell responses
against parasitized hepatocytes and leukocytes have been
demonstrated in infections with Plasmodium and Theileria
parasites, respectively (6-8), and, in the case of Plasmodium,
have been shown to confer protection in laboratory animal
models (9, 10). However, there is as yet no clear evidence that
these cytotoxic T-cell responses can control infections in
natural human and bovine hosts.
The most important species of Theileria in Africa is Theil-
eria parva, the causal agent of East Coast fever. T. parva
infects all lineages of lymphocytes and schizogeny is asso-
ciated with activation and proliferation of infected cells (11).
Synchrony of division of the schizont and host cell results in
rapid clonal expansion of parasitized cells. The parasite
therefore remains in an intracellular location throughout
much of this replicative stage of development, emerging only
when merozoites are produced and infect erythrocytes. Al-
though infection of susceptible animals results in high mor-
tality, animals that survive or those treated with anti-
theilerial drugs are immune to subsequent challenge with the
same strain of parasite (12). The transient appearance of
parasitized cells in immune cattle undergoing challenge with
T. parva indicates that protective immune responses in such
animals are directed against infected lymphocytes (8). Cell-
mediated cytotoxic activity for parasitized cells has been
observed in peripheral blood during the recovery phase of
primary and secondary infections. Detailed studies of the
responses in vivo and of cytotoxic T lymphocyte (CTL)
clones derived from immune cattle have demonstrated that
the effectors belong to the CD8+ subset of T cells, are class
I major histocompatibility complex (MHC)-restricted, are
specific for parasitized cells, and in some instances are
parasite strain specific (8, 13).
Herein we report the results of a study designed to deter-
mine the role of CD8+ T-cell responses in protection against
T. parva. The study employed lymphatic cannulation tech-
niques in conjunction with a limiting dilution analysis assay
ofCTL precursors (CTLp) to obtain precise quantitative data
on the kinetics of the CTL response in relation to infection.
The protective capacity of immune CD8+ T cells was dem-
onstrated by adoptive transfer of enriched populations of
CD8+ T cells obtained from responding lymph. The results of
this study provide direct evidence that CD8+ T cells can
control infections with T. parva.
MATERIALS AND METHODS
Animals and Surgery. Boran (Bos indicus) cattle reared
indoors under parasite-free conditions and aged between 3
and 12 months were used for the study. Monozygous twin
Abbreviations: CTL, cytotoxic T lymphocyte(s); CTLp, CTL pre-
cursor(s); ELL, efferent lymph lymphocyte(s); mAb, monoclonal
antibody; MHC, major histocompatibility complex; PBM, peripheral
blood mononuclear cell(s); FACS, fluorescence-activated cell sorter.
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calves were derived from surrogate dams implanted with split
embryos. Prescapular efferent lymphatic ducts were cannu-
lated essentially as described (14).
Immunization and Challe. Cattle were immunized with
the Muguga stock of T. parva by inoculation with an LD100
of International Laboratory for Research on Animal Diseases
sporozoite stabilate 3087 and simultaneous treatment with
long-acting oxytetracycline (12). Lethal challenge infections
were administered in the form of stabilated sporozoites or
triturated salivary glands of infected Rhipicephalus appen-
diculatus ticks. Immunizing and challenge inocula were ad-
ministered subcutaneously in the lateral aspect of the neck,
an area drained by the prescapular lymph node (15). Progress
of infection was monitored by microscopic examination of
lymph node puncture biopsies after staining with fluorescein
isothiocyanate-conjugatedbovineantiserumto T.parva schiz-
onts (8). Animals undergoing severe infections were treated
with parvaquone (Clexon, Pitman-Moore).
Cell Populations. Peripheral blood mononuclear cells
(PBM) were prepared by flotation on Ficoll-Paque (Pharma-
cia) as described (16). Efferent lymph lymphocytes (ELL)
were prepared in the same manner from short-term or over-
night collections of lymph. Fractionation of CD81 T cells
from fresh ELL for kinetic studies was conducted on a
fluorescence-activated cell sorter (FACS; Facstar Plus, Bec-
ton Dickinson) after staining with the bovine CD8-specific
monoclonal antibody (mAb) ILA51 (17). Sorting on the basis
of forward light scatter allowed fractionation of CD8+ cells
into large (blasting) and small populations. Because genera-
tion of the large numbers of cells required for in vivo transfer
studies was not possible by cell sorting techniques, CD8+ and
CD8- populations were prepared from overnight collections
of ELL by depletion of appropriate populations with rabbit
complement and lineage-specific mAb of IgG2a isotype.
Briefly, ELL for fractionation were suspended in RPMI 1640
medium (without Hepes buffer) supplemented with 10%
inactivated fetal bovine serum, 2 mM L-glutamine, 50 pM
2-mercaptoethanol, and 50 pg of gentamycin per ml (com-
plete medium) at a density of 1-5 x 108 cells per ml. mAbs
ILA50 [bovine immunoglobulin (18)], ILA58 [bovine immu-
noglobulin light chain (18)], ILA12 [bovine CD4 (19)], and
CC15 [WC1 specificity of bovine y8T cells (20)] were added
at dilutions approximating 50 times their saturated binding
concentration to delete bovine B cells, CD4+ T cells, and 'y8
T cells, respectively, the dominant non-CD8 lineages in
efferent lymph (Fig. 1A). The cell suspensions were then
incubated for 30 min on ice before the addition of rabbit
serum as a source of complement. Complement killing was
allowed to proceed for 40 min at 37°C and surviving cells were
collected by flotation on Ficoll-Paque. The degree of enrich-
ment was assessed by FACS analysis of surviving cells after
staining with a separate panel of mAbs, all of IgGl isotype:
CC30 [bovine CD4 (21)], ILA51 (bovine CD8 (17)], ILA29
[WC1; bovine 'y8 T cells (20)], ILA30 [bovine IgM; B cells
(22)]. In some instances a second cycle of complement lysis
was necessary to achieve satisfactory enrichment. To exam-
ine contaminating populations present in CD8+-enriched
ELL, CD8+ T cells in the fraction were depleted by com-
plement lysis with the CD8-specific mAb IL-A105 (IgG2a).
Monocytes or dendritic cells were consistently absent from
all ELL fractions, as determined by staining with mAb ILA24
(23).
Cell Lines. Transformed parasitized cell lines for use as
targets in limiting dilution microcultures and cytotoxicity
assays were prepared by in vitro infection of PBM with
sporozoites as described (24). Uninfected control cell lines
were Con A-stimulated lymphoblasts maintained by culture
in the presence of 10%1 T-cell growth factors (25).
Assays of Cellular Cytotoxicity. Direct parasite-specific
cytotoxic activity in whole and fractionated ELL and PBM
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FIG. 1. Phenotypic analysis of ELL populations prepared from
immune lymph collected on day 9 after challenge for cell transfer
experiments. (A) Unfiractionated ELL. (B) Population enriched for
CD8+ T cells by complement lysis of CD4+ T cells, B cells, and y8
T cells. (C) Population remaining in ELL after depetion ofCD4+ T
cells, B cells, 'y T cells, and CD8+ T cells, referred to herein as the
contaminant population.
was measured on 51Cr-labeled T. parva-infected cell lines
using a standard 4-hr 51Cr release assay (25) conducted in
flat-bottomed 96-well plates. Parasite specificity and MHC
restriction of cytotoxic activity were confirmed by the inclu-
sion in the assay of autologous Con A blasts and class I
MHC-mismatched infected cell lines. The fiequency of T.
parva-specific CTLp in these populations was determined by
limiting dilution analysis (26).
Inuunofluorescent Stainn. Cells were stained for pheno-
typic analysis by flow cytometry essentially as described
(27).
RESULTS
Knetics of CTL Activity in ELL and PBM. To examine the
kinetics of T. parva-specific CTL activity in blood and lymph
of immune cattle, and to assess the intensity of these re-
sponses, a group of five calves was immunized and chal-
lenged with the parasite. Direct cytotoxic activity and CTLp
frequencies were measured in ELL and PBM from these
cattle at various times after challenge. In line with previous
observations (8), MHC-restricted parasite-specific killing
was observed in PBM and ELL from all animals and coin-
cided roughly with the detection of schizont parasitosis in the
draining lymph node. Peak cytotoxic activity was observed
between days 9 and 11 and ranged from 17% to 78% at an
effector-to-target ratio of 40:1. The response was first de-
tected in efferent lymph on day 7 after challenge and ap-
peared in peripheral blood 1 day later. Frequencies of para-
site-specific CTLp in ELL and PBM were similar in samples
taken prior to this response (Fig. 2A). In keeping with
observations of direct cytotoxic activity, CTLp frequency in
ELL had increased considerably by day 7 after challenge and
peaked at values in excess of 1:40. As observed with direct
cytotoxic activity against the parasite, this increase appeared
later in PBM than ELL, and the frequencies were 20- to
30-fold less.
To locate the CTLp activity within ELL, cells were sorted
to purities of 95-98% into CD8+, CD8-, CD8+185c, and
CD8+ma subpopulations. The frequencies of CTLp in these
fractions indicated that they were all CD8+ and that the large
majority was blasting cells (Fig. 2B).
Preparation of Enriched ELL Subpopulats for Adoptive
Transfer. Three sets of monozygous twin calves were iden-
tified for adoptive transfer experiments, and one individual
from each set was immunized with T. parva. These animals
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FIG. 2. (A) Kinetic changes in the numbers of T. parva-specific
CTLp in PBM (v) and ELL (i) of an immune calf under challenge
with the immunizing stock of the parasite. (B) Frequency of T.
parva-specific CTLp in day 9 ELL fractionated on the basis of CD8
expression and cell size.
were challenged with a lethal dose of the parasite 6-8 weeks
after immunization, and the efferent lymphatic ofthe draining
lymph node was cannulated. Overnight collections of re-
sponding efferent lymph from these calves were used to
prepare cell populations for adoptive transfer. CD81 T-cell-
enriched fractions were prepared from two of the donors by
complement lysis of non-CD8 ELL lineages. FACS analysis
of these fractions revealed complete depletion of CD4+ T
cells and y6 T cells, with small numbers of contaminating B
cells remaining (Fig. 1B). Enrichment of CTL function was
confirmed by limiting dilution analysis (Table 1). However, a
contaminating population was present in these fractions that
was apparently negative for the expression ofCD4, CD8, and
the markers used in this study to define B cells and y8T cells.
It was not possible to identify a surface marker that defined
this population, but subsequent phenotypic analysis after
double-staining indicated that the dominant contaminating
cell was CD4- CD8- CD2+ CD5+ CD6+ (data not shown).
This population could be prepared for functional analysis by
complement lysis of enriched CD8+ cells and was prepared
in this manner from the third donor calffor adoptive transfer.
When tested by limiting dilution analysis the population did
Table 1. Temporal and quantitative details of three adoptive
transfer experiments between immune and naive monozygous
twin cattle under challenge with T. parva
No. of CTLp
Transfer cells frequency in
population Day* transferred inoculum % CD8+
CD8+ 9 (6) 0.5 x 109 1:31 85
10 (7) 2.0 x 109 ND 80
11 (8) 7.5 x 109 1:67 65
Total 1.0 x 1010
CD8+ 9 (6) 2.0 x 109 1:357 72
10 (7) 1.5 x 109 1:300 83
11 (8) 2.0 x 109 ND 83
12 (9) 3.0 x 109 ND 88
Total 8.5 x 109
Contaminant 9 (6) 2.0 x 107 <1:20,000
10 (7) 1.5 x 107 <1:20,000
11 (8) 2.5 x 108 <1:20,000
12 (9) 4.5 x 108 <1:20,000
Total 7.4 x 108
ND, not determined.
*Relative to challenge infection of donor; numbers in parentheses
denote the day of the recipient's infection.
not contain detectable CTLp (see Table 1) and was, in
addition, incapable of killing autologous infected or unin-
fected cell lines at an effector-to-target ratio of 20:1 in 4-hr or
overnight 51Cr assays (data not shown).
Adoptive Transfer ofELL Subpopulations Between Immune
and Naive Monozygous Twins After Challenge with T. panra.
In two experiments, naive calves undergoing lethal infection
with T. parva were inoculated with enriched CD8+ T cells
collected during the response of their immune monozygous
twins to challenge. Infections were contrived so that the peak
CTL response in donor lymph would coincide with the
appearance of parasites in the naive recipient, based on the
kinetic observations recorded above. Donor and recipient
calves were both challenged with a lethal dose of sporozoite
stabilate, and in each experiment a third age-matched sus-
ceptible control calf was also infected. The overnight har-
vests of lymph collected on days 9, 10, 11, and 12 after
challenge were used as sources of CD8+ cells for adoptive
transfer. This period corresponded to days 6, 7, 8, and 9 of
the recipient animal's infection. On each day of transfer,
CD8+-enriched ELL were suspended in 20 ml of autologous
plasma or fetal bovine serum and administered intravenously
to the recipient. Quantitative details of these transfer exper-
iments are summarized in Table 1. In both experiments the
viability and effector function of transferred CTL in the
recipient animals were confirmed by their detection in PBM
after transfer. In one of these animals CTL were detected in
PBM at a frequency of 1:7443 on the third day of transfer, by
which time it had received 2.5 x 109 cells (Table 1). Direct
cytotoxic activity was detected in PBM a day later and this
reached maximum levels 4 days after the final transfer (data
not shown).
The febrile reactions and kinetics of schizont parasitosis
observed in recipient and challenge control calves of these
experiments are illustrated in Fig. 3. Schizont-infected cells
were detected in the aspirates collected from the draining
lymph nodes of all animals between days 6 and 7 after
challenge. In the control calves the degree of parasitosis
increased steadily and by day 10 of infection had spread to
other peripheral lymph nodes. All of the control animals
developed clinical disease and required treatment on day 14,
with 30-50% parasitosis in the draining node and up to 20%
of the cells of the contralateral lymph node being infected. In
contrast, challenge infections in both recipients of CD8+-
enriched ELL were cleared without treatment. Parasites
were first detected on day 7 in these animals. In the first of
these experiments (Fig. 3 Top), parasitosis peaked at only 2%
on day 9 after challenge and was undetectable by day 12. In
the second experiment (Fig. 3 Middle), although the propor-
tion of parasitized cells in the draining node reached 12% on
day 10, the progress of infection was thereafter controlled.
Parasites were not detected in the contralateral lymph node
of either of these animals at any stage after challenge.
To ensure that the protection conferred on the recipient
calves was not the result of the transfer of CD8- lineages
contaminating the enriched CD8+ fraction, a third experi-
ment was conducted that involved the transfer of this pop-
ulation. The proportion of B cells remaining after comple-
ment lysis was somewhat higher than that seen in previous
experiments (Fig. 1C) and this was possibly attributable to
allelic variation in the immunoglobulin determinants recog-
nized by ILA50 and ILA58. In addition, a small proportion of
cells showing weak expression of CD8 consistently evaded
lysis. A total of 7.35 x 108 cells of the contaminating fraction
was transferred from the immune to the naive twin over a
4-day period. The kinetics of CTL activity in the donor twin
was similar to that seen in other immune animals, and the
timing of cell transfer was identical to that ofthe two previous
experiments. However, severe clinical reactions were ob-
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FIG. 3. Clinical and parasitological features of T. parva infections in untreated control calves and recipient calves after adoptive transfer
of immune CD8+ T cells (Top and Middle) and CD8- cells that persist after complement lysis of efferent lymph lymphocytes expressing CD4,
CD8, surface immunoglobulin, and the WC1 bovine yS T-cell marker (Bottom). Temperature reactions in control (r) and recipient (0) calves
and parasitosis in lymph nodes of control (o) and recipient (a) calves are indicated; >39.50C was considered febrile. Control calves of each
experiment and the recipient animal of the contaminant CD8- population were treated on day 14 of infection.
served in recipient and control animals that necessitated their
treatment on day 14 of infection (Fig. 3 Bottom).
DISCUSSION
The results of this study provide direct evidence that CD8+
T cells can protect immune cattle against challenge with T.
parva. In two separate experiments, lethally infected non-
immune calves received inoculations of enriched CD8+ re-
sponding T cells derived from their immune monozygous
twins to coincide with the emergence of patent schizont
parasitosis. In both animals the challenge infections were
subsequently confined to the regional lymph node and
cleared. Challenge control calves in each experiment devel-
oped generalized infections that required treatment. Several
features of the study support the conclusion that this effect is
mediated by parasite-specific class I MHC-restricted CTL. In
line with previous observations, the clearance of challenge
infections by immune cattle was in these experiments kinet-
ically associated with the appearance of parasite-specific
CTL in the circulation. Quantitative analysis ofCTL activity
in responding ELL after challenge with the parasite con-
firmed this association and, in addition, illustrated the vigor
of the nodal CTL response, with frequencies of parasite-
specific CTL as high as 1:31 at the peak of the response (Fig.
2A).
Previous studies of the kinetics of T. parva-specific CTL
responses in immune cattle have shown that activity appears
on day 8 after challenge, reaches peak levels on day 9 or 10,
and thereafter disappears rapidly (8). These observations
were based on assays of direct killing activity in PBM and are
difficult to interpret in quantitative terms. Limiting dilution
analysis has been shown to provide a more sensitive measure
of T. parva-specific CTL activity in PBM and also allows an
assessment of its intensity (26). However, because immune
responses are generated in the lymph node that drains the site
of antigenic challenge (28), the kinetics and intensity of T.
parva-specific CTL responses can be analyzed more directly
in cell populations leaving the responding node. CTL activity
was present in ELL 1 day earlier than in PBM and at this time
a substantial increase in the numbers of CTLp in lymph was
already apparent. At the peak of the nodal response to
infection, ELL contained parasite-specific CTLp at frequen-
cies as much as 25 times those observed in PBM. The
restriction of the CTL activity to the blasting cells of efferent
lymph indicates that this response was generated within the
node. Assuming a 1- to 2-day period for the expansion of
sufficient numbers of parasitized cells, their kinetics are
consistent with 4-5 days being required for the generation of
T. parva-specific CTL responses in immune cattle.
In vivo cell transfer experiments with cloned and polyclo-
nal cell lines have been used in other species to validate the
effector function of cell populations with defined specificities
(9, 29-32). Although T. parva-specific CTL lines can be
generated in the laboratory with relative ease, such experi-
ments are not practical in cattle because of the difficulties
associated with generating sufficient numbers of cultured
cells. The large quantities of T. parva-specific CTLp in
responding lymph represented an ideal alternative source of
CTL whose specificities were clearly relevant to in vivo
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responses. Although complement lysis of CD8- lineages
normally present in lymph provided a highly enriched CD8+
fraction, a contaminating CD8- population consistently re-
mained that was not apparent in unfractionated ELL. The
majority of these cells were found to be CD4- CD8- CD2+
CD5+ CD6+. This population contained no parasite-specific
CTLp (Table 1) or nonspecific cytolytic activity for MHC-
mismatched infected cells or uninfected autologous blasts
(data not shown). In addition, when transferred between
immune and naive twins in a third experiment, these cells did
not confer protection. The function of this population re-
mains unclear, but its phenotype suggests that it may be
analogous to the double-negative af3 T-cell receptor express-
ing T cells described in peripheral tissues of mouse and man
(reviewed in ref. 33). As evidenced by limiting dilution
analysis, the major T. parva-specific activity associated with
the CD8+ T-cell fraction of responding lymph was class I
MHC-restricted CTL function. Although the presence of
alternative mechanisms in this population cannot be ruled
out, it is therefore likely that the protection conferred by
transfer of enriched CD8+ ELL in these experiments was
mediated by parasite-specific CTL. It is improbable that the
control of infection in the recipient calves was due to endog-
enous CTL responses. It has been reported previously that
parasite-specific CTL responses cannot be detected in naive
cattle undergoing lethal challenge with T. parva (34) and the
control animals in our experiments did not develop detectable
CTL activity or CTLp at any time during the course of
infection (data not shown). The argument that endogenous
responses might somehow have been assisted by elements of
the transfer inoculum is disputed by the rapid appearance of
CTLp in the blood of the recipients after transfer. In one calf,
CTL activity was detected after only two daily inoculations,
by which time it had received 2.5 x 109 enriched CD8+
lymphocytes (Table 1). When compared with those observed
for the generation of CTL responses in immune cattle, these
kinetics are not consistent with endogenous CTL activity.
Although the results of this study indicate that immune
CD4+ lymphocytes are not required for the control of T.
parva infections in cattle, our experiments did not determine
whether these cells are capable of clearing the parasite. In
addition, their role in the induction of parasite-specific CTL
remains unclear. Experiments in other systems have pro-
vided equivocal data on the relative roles of CD8+ and CD4+
T cells in the resolution of infections with intracellular
pathogens. Both populations are capable of clearing influenza
infections of mice (29-31), and similar observations have
been made in murine malaria (9, 32). It is therefore possible
that T. parva-immune CD4+ cells are capable of effector
functions that might be significant in the absence of CD8+
CTL immunity. Additional transfer experiments are neces-
sary to examine these possibilities.
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